SEARCH

SEARCH BY CITATION

References

  • Barosi, G., Viarengo, G., Pecci, A., Rosti, V., Piaggio, G., Marchetti, M. & Frassoni, F. (2001) Diagnostic and clinical relevance of the number of circulating CD34(+) cells in myelofibrosis with myeloid metaplasia. Blood, 98, 32493255.
  • Barosi, G., Rosti, V., Massa, M., Viarengo, G.L., Pecci, A., Necchi, V., Ramaioli, I., Campanelli, R., Marchetti, M., Bazzan, M. & Magrini, U. (2004) Spleen neoangiogenesis in patients with myelofibrosis with myeloid metaplasia. British Journal of Haematology, 124, 618625.
  • Bock, O., Loch, G., Schade, U., Büsche, G., Von Wasielewski, R., Wiese, B. & Kreipe, H. (2005) Osteosclerosis in advanced chronic Idiopathic myelofibrosis is associated with endothelial overexpression of Osteoprotegerin (OPG). British Journal of Haematology, 160, 7682.
  • Bock, O., Neuse, J., Hussein, K., Brakensiek, K., Buesche, G., Buhr, T., Wiese, B. & Kreipe, H. (2006) Aberrant collagenase expression in chronic idiopathic myelofibrosis is related to the stage of disease but not to the JAK2 mutation status. American Journal of Pathology, 169, 471481.
  • Bock, O., Höftmann, J., Theophile, K., Hussein, K., Wiese, B., Schlué, J. & Kreipe, H. (2008) Bone morphogenetic proteins are overexpressed in the bone marrow of primary myelofibrosis and are apparently induced by fibrogenic cytokines. American Journal of Pathology, 172, 951960.
  • Carmona, G., Göttig, S., Orlandi, A., Scheele, J., Bäuerle, T., Jugold, M., Kiessling, F., Henschler, R., Zeiher, A.M., Dimmeler, S. & Chavakis, E. (2009) Role of the small GTPase Rap1 for integrin activity regulation in endothelial cells and angiogenesis. Blood, 113, 488497.
  • Centurione, L., Di Baldassarre, A., Zingariello, M., Bosco, D., Gatta, V., Rana, R.A., Langella, V., Di Virgilio, A., Vannucchi, A.M. & Migliaccio, A.R. (2004) Increased and pathologic emperipolesis of neutrophils within megakaryocytes associated with marrow fibrosis in GATA-1(low) mice. Blood, 104, 35733580.
  • Clay, D., Rubinstein, E., Mishal, Z., Anjo, A., Prenant, M., Jasmin, C., Boucheix, C. & Le Bousse-Kerdilès, M.C. (2001) CD9 and megakaryocyte differentiation. Blood, 97, 19821989.
  • Ten Dijke, P., Goumans, M.J. & Pardali, E. (2008) Endoglin in angiogenesis and vascular diseases. Angiogenesis, 11, 7989.
  • Gianelli, U., Vener, C., Raviele, P.R., Savi, F., Somalvico, F., Calori, R., Iurlo, A., Radaelli, F., Fermo, E., Bucciarelli, P., Bori, S., Coggi, G. & Deliliers, G.L. (2007) VEGF expression correlates with microvessel density in Philadelphia chromosome-negative chronic myeloproliferative disorders. American Journal of Clinial Pathology, 128, 966973.
  • Glodek, A.M., Le, Y., Dykxhoorn, D.M., Park, S.Y., Mostoslavsky, G., Mulligan, R., Lieberman, J., Beggs, H.E., Honczarenko, M. & Silberstein, L.E. (2007) Focal adhesion kinase is required for CXCL12-induced chemotactic and pro-adhesive responses in hematopoietic precursor cells. Leukemia, 21, 17231732.
  • Goumans, M.J., Valdimarsdottir, G., Itoh, S., Rosendahl, A., Sideras, P. & Ten Dijke, P. (2002) Balancing the activation state of the endothelium via two distinct TGF-beta type I receptors. EMBO Journal, 21, 17431753.
  • Goumans, M.J., Liu, Z. & Ten Dijke, P. (2009) TGF-beta signaling in vascular biology and dysfunction. Cell Research, 19, 116127.
  • Guglielmelli, P., Zini, R., Bogani, C., Salati, S., Pancrazzi, A., Bianchi, E., Mannelli, F., Ferrari, S., Le Bousse-Kerdilès, M.C., Bosi, A., Barosi, G., Migliaccio, A.R., Manfredini, R. & Vannucchi, A.M. (2007) Molecular profiling of CD34+ cells in idiopathic myelofibrosis identifies a set of disease-associated genes and reveals the clinical significance of Wilms’ tumor gene 1 (WT1). Stem Cells, 25, 165173.
  • Hartmann, E., Fernàndez, V., Moreno, V., Valls, J., Hernández, L., Bosch, F., Abrisqueta, P., Klapper, W., Dreyling, M., Hoster, E., Müller-Hermelink, H.K., Ott, G., Rosenwald, A. & Campo, E. (2008) Five-gene model to predict survival in mantle-cell lymphoma using frozen or formalin-fixed, paraffin-embedded tissue. Journal of Clinical Oncology, 26, 49664972.
  • Hayashida, T., Wu, M.H., Pierce, A., Poncelet, A.C., Varga, J. & Schnaper, H.W. (2007) MAP-kinase activity necessary for TGFbeta1-stimulated mesangial cell type I collagen expression requires adhesion-dependent phosphorylation of FAK tyrosine 397. Journal of Cell Science, 120 (Pt 23), 42304240.
  • Ko, E.M., Lee, I.Y., Cheon, I.S., Kim, J., Choi, J.S., Hwang, J.Y., Cho, J.S., Lee, D.H., Kang, D., Kim, S.H. & Choe, J. (2006) Monoclonal antibody to CD9 inhibits platelet-induced human endothelial cell proliferation. Molecular Cell, 22, 7077.
  • Kuter, D.J., Bain, B., Mufti, G., Bagg, A. & Hasserjian, R.P. (2007) Bone marrow fibrosis: pathophysiology and clinical significance of increased bone marrow stromal fibres. British Journal of Haematology, 139, 351362.
  • Lataillade, J.J., Pierre-Louis, O., Hasselbalch, H.C., Uzan, G., Jasmin, C., Martyre, M.C. & Le Bousse-Kerdiles, M.C. (2008) Does primary myelofibrosis involve a defective stem cell niche? From concept to evidence Blood, 112, 30263035.
  • Livak, K.J. & Schmittgen, T.D. (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2−ΔΔCT Method. Methods, 25, 402408.
  • Lundberg, L.G., Lerner, R., Sundelin, P., Rogers, R., Folkman, J. & Palmblad, J. (2000) Bone marrow in polycythemia vera, chronic myelocytic leukemia, and myelofibrosis has an increased vascularity. American Journal of Pathology, 157, 1519.
  • Maecker, H.T., Todd, S.C. & Levy, S. (1997) The tetraspanin superfamily: molecular facilitators. FASEB Journal, 11, 428442.
  • Migliaccio, A.R., Martelli, F., Verrucci, M., Migliaccio, G., Vannucchi, A.M., Ni, H., Xu, M., Jiang, Y., Nakamoto, B., Papayannopoulou, T. & Hoffman, R. (2008) Altered SDF-1/CXCR4 axis in patients with primary myelofibrosis and in the Gata1 low mouse model of the disease. Experimental Hematology, 36, 158171.
  • Nakamura, Y., Handa, K., Iwamoto, R., Tsukamoto, T., Takahasi, M. & Mekada, E. (2001) Immunohistochemical distribution of CD9, heparin binding epidermal growth factor-like growth factor, and integrin alpha3beta1 in normal human tissues. Journal of Histochemistry & Cytochemistry, 49, 439444.
  • Ponzoni, M., Savage, D.G., Ferreri, A.J., Pruneri, G., Viale, G., Servida, P., Bertolini, F. & Orazi, A. (2004) Chronic idiopathic myelofibrosis: independent prognostic importance of bone marrow microvascular density evaluated by CD105 (endoglin) immunostaining. Modern Pathology, 17, 15131520.
  • Rooke, H.M., Vitas, M.R., Crosier, P.S. & Crosier, K.E. (1999) The TGF-beta type II receptor in chronic myeloid leukemia: analysis of microsatellite regions and gene expression. Leukemia, 13, 535541.
  • Spivak, J.L. & Silver, R.T. (2008) The revised World Health Organization diagnostic criteria for polycythemia vera, essential thrombocytosis, and primary myelofibrosis: an alternative proposal. Blood, 112, 231239.
  • Steurer, M., Zoller, H., Augustin, F., Fong, D., Heiss, S., Strasser-Weippl, K., Gastl, G. & Tzankov, A. (2007) Increased angiogenesis in chronic idiopathic myelofibrosis: vascular endothelial growth factor as a prominent angiogenic factor. Human Pathology, 38, 10571064.
  • Tefferi, A. (2005) Pathogenesis of myelofibrosis with myeloid metaplasia. Journal of Clinical Oncology, 23, 85208530.
  • Tefferi, A. & Vardiman, J.W. (2008) Classification and diagnosis of myeloproliferative neoplasms: the 2008 World Health Organization criteria and point-of-care diagnostic algorithms. Leukemia, 22, 1422.
  • Theophile, K., Hussein, K., Kreipe, H. & Bock, O. (2008a) “Expression profiling of apoptosis-related genes in megakaryocytes: BNIP3 is down-regulated in primary myelofibrosis”. Experimental Hematology, 36, 17281738.
  • Theophile, K., Jonigk, D., Kreipe, H. & Bock, O. (2008b) “Amplification of mRNA from laser-microdissected single or clustered cells in formalin-fixed and paraffin-embedded tissues for application in quantitative real-time PCR”. Diagnostic Molecular Pathology, 17, 101106.
  • Thiele, J., Lorenzen, J., Manich, B., Kvasnicka, H.M., Zirbes, T.K. & Fischer, R. (1997) Apoptosis (programmed cell death) in idiopathic (primary) osteo-/myelofibrosis: naked nuclei in megakaryopoiesis reveal features of para-apoptosis. Acta Haematologica, 97, 137143.
  • Thiele, J., Kvasnicka, H.M., Facchetti, F., Franco, V., Van Der Walt, J. & Orazi, A. (2005) European consensus on grading bone marrow fibrosis and assessment of cellularity. Haematologica, 90, 11281132.
  • Tothill, R.W., Kowalczyk, A., Rischin, D., Bousioutas, A., Haviv, I., Van Laar, R.K., Waring, P.M., Zalcberg, J., Ward, R., Biankin, A.V., Sutherland, R.L., Henshall, S.M., Fong, K., Pollack, J.R., Bowtell, D.D. & Holloway, A.J. (2005) An expression-based site of origin diagnostic method designed for clinical application to cancer of unknown origin. Cancer Research, 65, 40314040.
  • Xu, M., Bruno, E., Chao, J., Huang, S., Finazzi, G., Fruchtman, S.M., Popat, U., Prchal, J.T., Barosi, G. & Hoffman, R., MPD Research Consortium (2005) Constitutive mobilization of CD34+ cells into the peripheral blood in idiopathic myelofibrosis may be due to the action of a number of proteases. Blood, 105, 45084515.